methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate

C46H56N4O8 — CID 88862855

IUPACmethyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
SMILESCCC1=CC2CN(CCc3c([nH]c4ccccc34)[C@@](COC=O)(c3cc4c(cc3CO)N(C)[C@H]3C(O)(C(=O)OC)[C@H](OC(C)=O)C5C(CC)=CCN6CC[C@]43[C@H]56)C2)C1
InChIInChI=1S/C46H56N4O8/c1-6-28-18-29-21-44(25-57-26-52,39-33(13-15-49(22-28)23-29)32-10-8-9-11-36(32)47-39)34-20-35-37(19-31(34)24-51)48(4)42-45(35)14-17-50-16-12-30(7-2)38(40(45)50)41(58-27(3)53)46(42,55)43(54)56-5/h8-12,18-20,26,29,38,40-42,47,51,55H,6-7,13-17,21-25H2,1-5H3/t29?,38?,40-,41+,42+,44-,45+,46?/m0/s1
InChIKeyBRWVATOABUMUEN-ZEHMZERFSA-N
MW792.97 g/mol
LogP4.28
Rot. Bonds9

About methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate

methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate (PubChem CID 88862855) has the molecular formula C46H56N4O8 and a molecular weight of 792.97 g/mol. Its IUPAC name is methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate.

Molecular Properties

Compound Namemethyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
PubChem CID88862855
Molecular FormulaC46H56N4O8
Molecular Weight792.97 g/mol
Exact Mass792.41
IUPAC Namemethyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate
SMILESCCC1=CC2CN(CCc3c([nH]c4ccccc34)[C@@](COC=O)(c3cc4c(cc3CO)N(C)[C@H]3C(O)(C(=O)OC)[C@H](OC(C)=O)C5C(CC)=CCN6CC[C@]43[C@H]56)C2)C1
InChIInChI=1S/C46H56N4O8/c1-6-28-18-29-21-44(25-57-26-52,39-33(13-15-49(22-28)23-29)32-10-8-9-11-36(32)47-39)34-20-35-37(19-31(34)24-51)48(4)42-45(35)14-17-50-16-12-30(7-2)38(40(45)50)41(58-27(3)53)46(42,55)43(54)56-5/h8-12,18-20,26,29,38,40-42,47,51,55H,6-7,13-17,21-25H2,1-5H3/t29?,38?,40-,41+,42+,44-,45+,46?/m0/s1
InChIKeyBRWVATOABUMUEN-ZEHMZERFSA-N
XLogP4.28
TPSA144.87 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500792.97
LogP ≤ 54.28
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate?
The IUPAC name of methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate (CID 88862855) is methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate.
What is the SMILES notation for methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate?
The canonical SMILES for methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate is CCC1=CC2CN(CCc3c([nH]c4ccccc34)[C@@](COC=O)(c3cc4c(cc3CO)N(C)[C@H]3C(O)(C(=O)OC)[C@H](OC(C)=O)C5C(CC)=CCN6CC[C@]43[C@H]56)C2)C1.
What is the InChIKey of methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate?
The InChIKey is BRWVATOABUMUEN-ZEHMZERFSA-N. The full InChI is InChI=1S/C46H56N4O8/c1-6-28-18-29-21-44(25-57-26-52,39-33(13-15-49(22-28)23-29)32-10-8-9-11-36(32)47-39)34-20-35-37(19-31(34)24-51)48(4)42-45(35)14-17-50-16-12-30(7-2)38(40(45)50)41(58-27(3)53)46(42,55)43(54)56-5/h8-12,18-20,26,29,38,40-42,47,51,55H,6-7,13-17,21-25H2,1-5H3/t29?,38?,40-,41+,42+,44-,45+,46?/m0/s1.
What are the key properties of methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate?
methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate has a molecular weight of 792.97 g/mol, XLogP of 4.28, 9 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (1R,9R,11R,19S)-11-acetyloxy-13-ethyl-4-[(13S)-17-ethyl-13-(formyloxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-(hydroxymethyl)-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate is sourced from PubChem (CID 88862855), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).